Billiontoone, Inc. (BLLN) – What Are Investment Firms Saying About This Stock?

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) has received an average recommendation of “Moderate Buy” from the eleven analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $124.38.

A number of research analysts have weighed in on BLLN shares. Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Canaccord Genuity Group started coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price on the stock. Piper Sandler lowered their target price on shares of Billiontoone from $140.00 to $130.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 10th. JPMorgan Chase & Co. raised their target price on Billiontoone from $130.00 to $135.00 and gave the company an “overweight” rating in a research report on Thursday, November 5th. Finally, BTIG Research restated a “buy” rating and issued a $130.00 price target on shares of Billiontoone in a research note on Thursday, November 5th.

Check Out Our Latest Analysis on Billiontoone

Billiontoone Stock Performance

Shares of NASDAQ BLLN opened at $105.15 on Monday. The company’s fifty day moving average price is $106.99 and its 200 day moving average price is $97.74. Billiontoone has a 1 year low of $61.96 and a 1 year high of $150.44. The company has a market capitalization of $5.02 billion and a PE ratio of 114.29. The company has a debt-to-equity ratio of 0.16, a quick ratio of 10.89 and a current ratio of 11.25.

Insiders Place Their Bets

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total value of $1,975,400.00. Following the sale, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at approximately $98,770. This trade represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 25,001 shares of the firm’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total value of $2,731,109.24. Following the completion of the sale, the chief executive officer directly owned 16,667 shares in the company, valued at approximately $1,820,703.08. The trade was a 60.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 252,777 shares of company stock worth $26,737,151. 50.22% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Billiontoone

A number of institutional investors have recently added to or reduced their stakes in the stock. Marshall Wace LLP increased its stake in shares of Billiontoone by 620.0% during the third quarter. Marshall Wace LLP now owns 321,546 shares of the company’s stock worth $34,225,000 after purchasing an additional 276,884 shares in the last quarter. Aberdeen Group plc acquired a new position in shares of Billiontoone during the 3rd quarter worth about $19,565,000. Wasatch Advisors LP raised its position in shares of Billiontoone by 40.2% during the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares during the last quarter. State Street Corp lifted its stake in Billiontoone by 101.7% in the 3rd quarter. State Street Corp now owns 144,075 shares of the company’s stock valued at $15,335,000 after buying an additional 72,639 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new position in Billiontoone in the 1st quarter valued at about $4,046,000.

About Billiontoone

(Get Free Report)

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

Further Reading

Analyst Recommendations for Billiontoone (NASDAQ:BLLN)

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.